2024 Q2 Form 10-Q Financial Statement

#000088634624000092 Filed on May 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q2
Revenue $274.8M $249.0M $229.8M
YoY Change 19.59% 1.45%
Cost Of Revenue $152.9M $138.0M $127.7M
YoY Change 19.71% -0.43%
Gross Profit $121.9M $111.0M $102.0M
YoY Change 19.44% 3.9%
Gross Profit Margin 44.36% 44.57% 44.41%
Selling, General & Admin $70.00M $70.31M $58.56M
YoY Change 19.54% -1.02%
% of Gross Profit 57.43% 63.36% 57.39%
Research & Development $3.482M $3.730M $3.370M
YoY Change 3.32% 9.49%
% of Gross Profit 2.86% 3.36% 3.3%
Depreciation & Amortization $11.99M $11.74M $8.446M
YoY Change 41.97% -10.58%
% of Gross Profit 9.84% 10.58% 8.28%
Operating Expenses $73.49M $74.04M $61.93M
YoY Change 18.66% -0.5%
Operating Profit $48.40M $36.93M $40.11M
YoY Change 20.66% -28.33%
Interest Expense -$4.833M -$4.058M -$2.071M
YoY Change 133.37% -267.83%
% of Operating Profit -9.99% -10.99% -5.16%
Other Income/Expense, Net -$2.000K -$30.00K -$21.00K
YoY Change -90.48% -4.55%
Pretax Income $43.57M $32.84M $38.02M
YoY Change 14.58% -30.64%
Income Tax $11.99M $7.854M $9.763M
% Of Pretax Income 27.53% 23.92% 25.68%
Net Earnings $31.29M $24.69M $28.08M
YoY Change 11.46% -31.84%
Net Earnings / Revenue 11.39% 9.92% 12.22%
Basic Earnings Per Share $2.66 $2.11 $2.40
Diluted Earnings Per Share $2.66 $2.10 $2.40
COMMON SHARES
Basic Shares Outstanding 11.74M shares 11.72M shares 11.68M shares
Diluted Shares Outstanding 11.77M shares 11.74M shares 11.69M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $75.18M $82.62M $85.51M
YoY Change -12.08% -0.79%
Cash & Equivalents $75.18M $82.62M $85.51M
Short-Term Investments
Other Short-Term Assets $41.81M $39.91M $41.74M
YoY Change 0.16% 68.15%
Inventory $173.5M $172.0M $179.2M
Prepaid Expenses
Receivables $164.8M $160.3M $143.7M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $413.5M $414.8M $408.4M
YoY Change 1.26% 4.1%
LONG-TERM ASSETS
Property, Plant & Equipment $174.2M $170.8M $120.3M
YoY Change 44.82% 13.63%
Goodwill $478.0M $459.9M $387.9M
YoY Change 23.24% -1.65%
Intangibles $289.7M $273.8M $171.4M
YoY Change 69.02% -10.93%
Long-Term Investments
YoY Change
Other Assets $100.6M $90.01M $81.22M
YoY Change 23.85% 36.97%
Total Long-Term Assets $1.043B $994.6M $760.8M
YoY Change 37.03% 1.17%
TOTAL ASSETS
Total Short-Term Assets $413.5M $414.8M $408.4M
Total Long-Term Assets $1.043B $994.6M $760.8M
Total Assets $1.456B $1.409B $1.169B
YoY Change 24.54% 2.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $54.42M $55.59M $57.94M
YoY Change -6.08% -14.5%
Accrued Expenses $38.25M $35.63M $30.34M
YoY Change 26.09% -1.15%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.233M $1.991M $3.352M
YoY Change -3.55% -31.49%
Total Short-Term Liabilities $54.42M $57.58M $57.94M
YoY Change -6.08% -73.37%
LONG-TERM LIABILITIES
Long-Term Debt $345.3M $308.0M $180.1M
YoY Change 91.66% -25.85%
Other Long-Term Liabilities $238.0M $249.1M $246.8M
YoY Change -3.56% 452.65%
Total Long-Term Liabilities $583.2M $557.1M $426.9M
YoY Change 36.62% 856.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $54.42M $57.58M $57.94M
Total Long-Term Liabilities $583.2M $557.1M $426.9M
Total Liabilities $637.6M $614.7M $484.8M
YoY Change 31.52% 84.89%
SHAREHOLDERS EQUITY
Retained Earnings $811.6M $784.1M $685.3M
YoY Change 18.42% 16.16%
Common Stock $146.0K $146.0K $146.0K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $818.4M $794.8M $684.3M
YoY Change
Total Liabilities & Shareholders Equity $1.456B $1.409B $1.169B
YoY Change 24.54% 2.17%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q2
OPERATING ACTIVITIES
Net Income $31.29M $24.69M $28.08M
YoY Change 11.46% -31.84%
Depreciation, Depletion And Amortization $11.99M $11.74M $8.446M
YoY Change 41.97% -10.58%
Cash From Operating Activities $28.07M $22.83M $36.87M
YoY Change -23.87% 55.11%
INVESTING ACTIVITIES
Capital Expenditures $4.974M $6.271M $4.469M
YoY Change 11.3% 55.82%
Acquisitions $232.3M $0.00
YoY Change -100.0%
Other Investing Activities -$59.28M $0.00 $30.00K
YoY Change -197703.33% -168.18%
Cash From Investing Activities -$64.25M -$237.3M -$4.467M
YoY Change 1338.44% 246.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 29.93M $192.9M -$27.76M
YoY Change -207.84% 2.79%
NET CHANGE
Cash From Operating Activities 28.07M $22.83M $36.87M
Cash From Investing Activities -64.25M -$237.3M -$4.467M
Cash From Financing Activities 29.93M $192.9M -$27.76M
Net Change In Cash -6.257M -$23.84M $5.782M
YoY Change -208.22% -211.41%
FREE CASH FLOW
Cash From Operating Activities $28.07M $22.83M $36.87M
Capital Expenditures $4.974M $6.271M $4.469M
Free Cash Flow $23.09M $16.56M $32.40M
YoY Change -28.72% 55.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
138013000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
127712000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
70305000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
58562000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3730000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3370000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
212048000 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
189644000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
36927000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
40114000 usd
CY2024Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
611000 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
299000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
4669000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
2370000 usd
CY2024Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
30000 usd
CY2023Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
21000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
32839000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
38022000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7854000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9763000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
24985000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
28259000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
296000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
184000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
24689000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
28075000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.11
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.40
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.10
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.40
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11724000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11681000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11744000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11694000 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
24985000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
28259000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-10222000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
5573000 usd
CY2024Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
-2000 usd
CY2024Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
1000 usd
CY2023Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-6000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
13000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
-14000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
38000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-39000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10183000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5528000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
14802000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
33787000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
224000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
219000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14578000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
33568000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
296000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
184000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
24985000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
28259000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11739000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8446000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2415000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2238000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
413000 usd
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
13000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-803000 usd
CY2023Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-829000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7956000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-517000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
2425000 usd
CY2023Q2 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-2637000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6721000 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13997000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-609000 usd
CY2023Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1293000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
15036000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
77000 usd
CY2024Q1 kai Increase Decrease In Contract With Customer Liability Customer Deposits
IncreaseDecreaseInContractWithCustomerLiabilityCustomerDeposits
-778000 usd
CY2023Q2 kai Increase Decrease In Contract With Customer Liability Customer Deposits
IncreaseDecreaseInContractWithCustomerLiabilityCustomerDeposits
11114000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-15289000 usd
CY2023Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-4560000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
22831000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
36866000 usd
CY2024Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
232261000 usd
CY2023Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6271000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4469000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1269000 usd
CY2023Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
32000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
CY2023Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
30000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-237263000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4467000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
234000000 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 usd
CY2024Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
33450000 usd
CY2023Q2 us-gaap Repayments Of Debt
RepaymentsOfDebt
20761000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5855000 usd
CY2023Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3897000 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3395000 usd
CY2023Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3036000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1605000 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
CY2023Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-63000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
192905000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-27757000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2308000 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1140000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-23835000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5782000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106453000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79725000 usd
CY2024Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
3758000 usd
CY2023Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
3394000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
82618000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
85507000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
776240000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
24985000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.32
CY2024Q1 us-gaap Dividends
Dividends
3758000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1835000 usd
CY2024Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
9319000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10183000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
794768000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
655571000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
28259000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.29
CY2023Q2 us-gaap Dividends
Dividends
3394000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1659000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5528000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
684305000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates and Critical Accounting Policies</span></div>The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Although the Company makes every effort to ensure the accuracy of the estimates and assumptions used in the preparation of its condensed consolidated financial statements or in the application of accounting policies, if business conditions were different, or if the Company were to use different estimates and assumptions, it is possible that materially different amounts could be reported in the Company's condensed consolidated financial statements.
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
4484000 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
2161000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7313000 usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9558000 usd
CY2024Q1 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
266061000 usd
CY2023Q2 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
0 usd
CY2024Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
238306000 usd
CY2023Q2 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 usd
CY2024Q1 kai Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed And Noncontrolling Interests Acquired
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumedAndNoncontrollingInterestsAcquired
-27755000 usd
CY2023Q2 kai Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed And Noncontrolling Interests Acquired
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumedAndNoncontrollingInterestsAcquired
0 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1342000 usd
CY2023Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
299000 usd
CY2024Q1 us-gaap Stock Issued1
StockIssued1
4703000 usd
CY2023Q2 us-gaap Stock Issued1
StockIssued1
4246000 usd
CY2024Q1 kai Bank Guarantee Expiration Period
BankGuaranteeExpirationPeriod
P12M
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81440000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81183000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103832000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76371000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1178000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
4324000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2621000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3354000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
82618000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
85507000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106453000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79725000 usd
CY2024Q1 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
70695000 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
66738000 usd
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
41180000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
32147000 usd
CY2024Q1 us-gaap Other Inventory Inventory At Off Site Premises
OtherInventoryInventoryAtOffSitePremises
3581000 usd
CY2023Q4 us-gaap Other Inventory Inventory At Off Site Premises
OtherInventoryInventoryAtOffSitePremises
5182000 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
60083000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
53792000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
171958000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
152677000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
437056000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
181153000 usd
CY2024Q1 kai Finite Lived Intangible Assets Accumulated Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsAccumulatedForeignCurrencyTranslationGainLoss
-10400000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
245503000 usd
CY2024Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
466115000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
181153000 usd
CY2024Q1 kai Intangible Assets Excluding Goodwill Accumulated Foreign Currency Translation Gain Loss
IntangibleAssetsExcludingGoodwillAccumulatedForeignCurrencyTranslationGainLoss
-11131000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
273831000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
313894000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
174282000 usd
CY2023Q4 kai Finite Lived Intangible Assets Accumulated Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsAccumulatedForeignCurrencyTranslationGainLoss
-8921000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
130691000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
342953000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
174282000 usd
CY2023Q4 kai Intangible Assets Excluding Goodwill Accumulated Foreign Currency Translation Gain Loss
IntangibleAssetsExcludingGoodwillAccumulatedForeignCurrencyTranslationGainLoss
-9385000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
159286000 usd
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
477622000 usd
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
85538000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
392084000 usd
CY2024Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
72526000 usd
CY2024Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-22000 usd
CY2024Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-4671000 usd
CY2024Q1 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
67833000 usd
CY2024Q1 us-gaap Goodwill Gross
GoodwillGross
545455000 usd
CY2024Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
85538000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
459917000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
8154000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
7283000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1069000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1425000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
724000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1068000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Additions From Business Acquisition
StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition
475000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual Additions From Business Acquisition
StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition
0 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-150000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss
87000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
8824000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
7727000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
248975000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
229758000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
248975000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
229758000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
248975000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
229758000 usd
CY2024Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
10673000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
8366000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
78856000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
79397000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
33666000 usd
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
27016000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
37026000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.88
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.12
CY2024Q1 kai Bank Acceptance Maturity Period
BankAcceptanceMaturityPeriod
P6M
CY2024Q1 us-gaap Due From Customer Acceptances
DueFromCustomerAcceptances
6723000 usd
CY2023Q4 us-gaap Due From Customer Acceptances
DueFromCustomerAcceptances
10826000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.40
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.10
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.40
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
24689000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
28075000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11724000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11681000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
20000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
13000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11744000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11694000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.11
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7854000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9763000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.24
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.26
CY2024Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
1992000 usd
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
1789000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
310016000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
110875000 usd
CY2024Q1 us-gaap Debt Current
DebtCurrent
3243000 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
3209000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
306773000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
107666000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2415000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2238000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
15745000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M6D
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
248975000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
229758000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
36927000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
40114000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-4058000 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2071000 usd
CY2024Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
30000 usd
CY2023Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
21000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
32839000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
38022000 usd
CY2024Q1 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
6271000 usd
CY2023Q2 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
4469000 usd
CY2024Q1 us-gaap Assets
Assets
1409426000 usd
CY2023Q4 us-gaap Assets
Assets
1175665000 usd
CY2024Q1 kai Bank Acceptance Maturity Period
BankAcceptanceMaturityPeriod
P6M
CY2024Q1 us-gaap Bank Acceptances Executed
BankAcceptancesExecuted
4524000 usd
CY2023Q4 us-gaap Bank Acceptances Executed
BankAcceptancesExecuted
9090000 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000886346-24-000092-index-headers.html Edgar Link pending
0000886346-24-000092-index.html Edgar Link pending
0000886346-24-000092.txt Edgar Link pending
0000886346-24-000092-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kai-20240330.htm Edgar Link pending
kai-20240330.xsd Edgar Link pending
kaiform10q1q2024ex311.htm Edgar Link pending
kaiform10q1q2024ex312.htm Edgar Link pending
kaiform10q1q2024ex32.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
kai-20240330_def.xml Edgar Link unprocessable
kai-20240330_lab.xml Edgar Link unprocessable
kai-20240330_pre.xml Edgar Link unprocessable
kai-20240330_htm.xml Edgar Link completed
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
kai-20240330_cal.xml Edgar Link unprocessable